Mobia Medical grants stock options to director Curet

Mobia Medical, Inc. director Myriam Curet received two stock option awards on 2026-07-30: one for 19,740 options and another for 15,960 options, each exercisable for common stock at an exercise price of $11.1800 per share.

Rhea-AI Filing Summary

Mobia Medical, Inc. director Myriam Curet received two stock option awards on 2026-07-30: one for 19,740 options and another for 15,960 options, each exercisable for common stock at an exercise price of $11.1800 per share. The first option vests in three substantially equal annual installments on the first three anniversaries of the grant date; the second fully vests at the 2027 Annual Meeting under the Non-Employee Director Compensation Policy. Both options expire on 2036-07-30.

Insider Trade Summary

Grant/Award: 35,700 shares

Grant/Award 2 txns

Insider Curet Myriam

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option F1	19,740	$0.00	$0.00
Grant/Award	Stock Option F2	15,960	$0.00	$0.00

Holdings After Transaction: Stock Option — 35,700 contracts (Direct)

Footnotes (2)

1. F1. The stock option will vest in three substantially equal installments on the first three anniversaries of the grant date.
2. F2. The stock option will fully vest at the 2027 Annual Meeting, consistent with the Non-Employee Director Compensation Policy.

Key Figures

Option grant size 1: 19,740 options Option grant size 2: 15,960 options Exercise price: $11.1800 per share +2 more

5 metrics

Option grant size 1 19,740 options Stock option award to director Myriam Curet on 2026-07-30

Option grant size 2 15,960 options Second stock option award to director Myriam Curet on 2026-07-30

Exercise price $11.1800 per share Conversion or exercise price for both option grants

Option expiration 2036-07-30 Expiration date for both stock option grants

Vesting schedule 3 annual installments / full vest at 2027 meeting One grant vests over three anniversaries; the other at the 2027 Annual Meeting

Key Terms

Stock option, Non-Employee Director Compensation Policy, grant date

3 terms

Stock option financial

"The stock option will vest in three substantially equal installments..."

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

Non-Employee Director Compensation Policy financial

"consistent with the Non-Employee Director Compensation Policy."

grant date financial

"on the first three anniversaries of the grant date."

The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider equity awards did Mobia Medical (MOBI) report for director Myriam Curet?

Mobia Medical reported that director Myriam Curet received two stock option awards on 2026-07-30, covering 19,740 and 15,960 underlying common shares. Both are option grants, not market purchases or sales, and provide potential future ownership at a fixed exercise price.

What are the exercise terms of Myriam Curet’s Mobia Medical (MOBI) stock options?

Each option grant to Myriam Curet has an exercise price of $11.1800 per share for Mobia Medical common stock. The options are derivative awards with no cash paid at grant and can be exercised for shares before their 2036-07-30 expiration, subject to vesting.

How do the Mobia Medical (MOBI) stock options granted to Myriam Curet vest?

One stock option for 19,740 shares vests in three substantially equal installments on the first three anniversaries of the grant date. The second, for 15,960 shares, will fully vest at the 2027 Annual Meeting, consistent with the Non-Employee Director Compensation Policy.

When do Myriam Curet’s Mobia Medical (MOBI) stock options expire?

Both stock option grants to Myriam Curet are scheduled to expire on 2036-07-30. She can exercise vested portions any time before that expiration date, subject to the company’s plan terms and applicable securities regulations governing option exercises.

Were Myriam Curet’s Mobia Medical (MOBI) option grants made under a Rule 10b5-1 plan?

The filing’s Rule 10b5-1 checkbox is not checked, indicating these reported transactions were not affirmatively designated as undertaken under a Rule 10b5-1 trading plan. They are described as stock option grants awarded on the grant date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/03/2026 - 06:12 PM Accepted by SEC EDGAR 08/03/2026 - 06:11 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Curet Myriam

(Last) (First) (Middle)

2802 FLINTROCK TRACE, SUITE 226

(Street)

AUSTIN TEXAS 78738

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Mobia Medical, Inc. [ MOBI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$11.18	07/30/2026		A		19,740		(1)	07/30/2036	Common Stock	19,740	$0	19,740	D
Stock Option	$11.18	07/30/2026		A		15,960		(2)	07/30/2036	Common Stock	15,960	$0	15,960	D

Explanation of Responses:

1. The stock option will vest in three substantially equal installments on the first three anniversaries of the grant date.

2. The stock option will fully vest at the 2027 Annual Meeting, consistent with the Non-Employee Director Compensation Policy.

	/s/ Chase Leavitt, Attorney-in-Fact	08/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)